This browser is not actively supported anymore. For the best passle experience, we strongly recommend you upgrade your browser.
| less than a minute read

The anonymisaton quandary

Anonymisation is an issue that comes up time and time again for our clients, in both the life sciences and tech sectors, and in particular where these two themes converge in the health tech arena. 

When can anonymisation be used? How do you know whether data has been rendered legally anonymous? What is the "motivated intruder" test and how should it be applied? 

The truth is that it remains a grey area whilst both UK and EU regulatory guidance lags behind the GPDR. It is also an area that involves challenging legal but also technical questions. 

Bristows and Privitar have joined forces to produce this helpful overview note that covers the legal, technological and business issues relating to anonymisation in the UK, along with consideration of the divergence in position across the EU. It will be of interest to any organisation seeking to anonymise the data they already hold or looking to procure "anonymised" data from a third party. 

Anonymisation is sometimes presented as a silver bullet; a way to use data outside of the scope of data protection law. However, in practice anonymisation is complex and is not always appropriate.

Tags

data protection and privacy, life sciences, health tech, it and digital